Efficacy of Camellia sinensis extract against Candida species in patients with denture stomatitis
Denture stomatitis is a chronic inflammation disease of the oral mucosa, which is specified by erythematous lesions mainly in the upper palate. Nystatin as a polyene, a class of antifungal agents, is one of the effective drugs to treat denture stomatitis. Considering the expansion of utilizing herba...
Gespeichert in:
Veröffentlicht in: | Current medical mycology 2018-09, Vol.4 (3), p.15-18 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Denture stomatitis is a chronic inflammation disease of the oral mucosa, which is specified by erythematous lesions mainly in the upper palate. Nystatin as a polyene, a class of antifungal agents, is one of the effective drugs to treat denture stomatitis. Considering the expansion of utilizing herbal drugs to cure many kinds of diseases, the present study was conducted to investigate the effects of
(green tea), which has the most chemical and influence similarity with nystatin, against denture stomatitis.
This study was conducted on 22 patients with a positive mycological evidence for denture stomatitis caused by
species. The study population was divided into two groups, namely green tea and nystatin, receiving green tea mouthwash 0.5% and nystatin suspension 100,000 U/ml, respectively. The lesion size and number of yeast colonies were measured before and after the treatment.
According to the results, both groups showed reduced lesion size, clinical improvement, and significant reduction of
colony count in both group of patients were showedafter the therapeutic. Based on the results of polymerase chain reaction,
was the most common species isolated from denture stomatitis. There was no significant difference between the two study groups in terms of
species distribution (
).
Green tea demonstrated a comparable anti-
activity with regard to nystatin; therefore, it could be recommended as an alternative treatment. |
---|---|
ISSN: | 2423-3439 2423-3420 |
DOI: | 10.18502/cmm.4.3.174 |